4 Takeaways from Martin Makary’s Confirmation Hearing to Lead FDA
Senators on Thursday pressed President Donald Trump’s pick to lead the Food and Drug Administration on the agency’s recent cancellation of a vaccine advisory committee meeting as well as his policy ...
KNAU Arizona Public Radio49m
5 takeaways from the confirmation hearing for Trump's FDA nominee
Dr. Marty Makary, President Trump's pick to run the Food and Drug Administration, faced questions from the Senate HELP ...
JD Supra4h
HHS Issues Policy Statement to Expand Use of Rulemaking Without Notice and Comment
The policy statement aims to bring more rapid action on personnel and management decisions and empowers HHS and each of its offices and subagencies ...
The Berkshire Eagle13hOpinion
Word of the Week: Newspeak. Orwell's prescient prediction of modern censorship models
Words matter. Government-imposed elimination of words and violation of constitutionally-protected free press guarantees ...
PharmiWeb2d
Protagonist and Takeda Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide in Patients with Polycythemia Vera
Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) today announced positive topline results for the Phase 3 VERIFY study, in which phlebotomy-dependent ...
Curaleaf Holdings, Inc.: Curaleaf Reports Fourth Quarter and Full Year 2024 Results
Full year operating cash flow from continuing operations of $163 million and free cash flow from continuing operations of $70 million ...
A Navy vet was given ‘weeks to live’ in 2020. Now his cancer treatment is at risk.
Due to federal research cuts, Navy veteran Kyle Lewis says he won't be able to receive the cancer treatment that saved his life.
Crain's New York Business3d
Midtown biotech raises $250M to bring lung cancer therapy to market
Life science firm Nuvation Bio raised $250 million to bring its novel lung cancer therapy to market and help it reach ...
A 55-year-old longevity doctor says he's healthier than he was 20 years ago. Here is his biggest tip for living longer.
Dr. Shai Efrati, a professor of medicine, does experimental treatments in the hope he will age well. But his top tip for ...
Infectious Disease Advisor3d
Twice-Yearly Lenacapavir Gets Priority Review For HIV PrEP
The FDA has accepted under Priority Review the NDA for lenacapavir for the prevention of HIV as pre-exposure prophylaxis.
The Manila Times7d
VANTAGE FILES FDA DRUG MASTER FILE FOR VYCERIN™ API GLYCERIN, USP DESIGNED SPECIFICALLY TO MEET PHARMACEUTICAL FORMULATION NEEDS
Vantage Specialty Chemicals, Inc., (Vantage) today announced that its VYCERIN™ API Glycerin, USP is listed on the Drug Master File (DMF-040171) with the U.S. Food and Drug Administration (FDA).
The Manila Times8d
Cognition Therapeutics Successfully Passes Pre-defined Futility Analysis of Phase 2 Study of Oral Zervimesine (CT1812) in Geographic Atrophy
To date, the MAGNIFY study ( NCT05893537) has enrolled 100 participants. All participants are completing a final clinic visit in February 2025. Cognition intends to unblind the study at the end of ...